Email marketing News
recent headlines ...
News-to-Response Package Increases Relevance of Newsletter Content ...
Email-marketing specialist Publicare has introduced a new end-to-end service package for electronic newsletters: N2R (News-to-Response). Publicare manages the entire newsletter process, from content sourcing to reporting of results. A key focus is on identifying and developing subject matter that reflects the interests of the target group, improving the response and retention rate.
Source: PRWeb via Yahoo! News (Mon, 01 Dec 2008 16:15:00 GMT)
Contactology?s Real-Time Reporting Helping PASTE Magazine Routinely Sell-out...
Contactology , a provider of email marketing and online survey technologies, announced today that PASTE Media Group, publisher of PASTE Magazine, has employed its technology to push advertising-based newsletters to the magazine?s extensive database of opt-in subscribers. PASTE Magazine, one of the fastest-growing independently published entertainment magazines in the country, boasts a database ...
Source: Centre Daily Times (Tue, 02 Dec 2008 13:43:01 GMT)
Wyeth Submits European Marketing Authorization Application For 13-Valent...
Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), announced today that it has submitted a marketing authorization application (MAA) to the European Medicines Agency (EMEA) for approval to market its investigational 13-valent pneumococcal conjugate vaccine (PCV13) for infants and young children.
Source: Medical News Today (Wed, 03 Dec 2008 19:06:01 GMT)
Contactologys Real-Time Reporting Helping PASTE Magazine Routinely Sell-out...
DURHAM, N.C.----Contactology, a provider of email marketing and online survey technologies, announced today that PASTE Media Group, publisher of PASTE Magazine, has employed its technology to push advertising-based newsletters to the magazine?s extensive database of opt-in subscribers.
Source: Business Wire via Yahoo! Finance (Tue, 02 Dec 2008 13:00:00 GMT)
Good, Bad And Ugly In Food Marketing Focus Of $6.4 Million Childhood Obesity...
The link between food marketing and the growing childhood obesity epidemic is the focus of a $6.4 million grant from the Robert Wood Johnson Foundation to the Rudd Center for Food Policy and Obesity at Yale University. Principal investigators, Rudd Center Director Kelly D.
Source: Medical News Today (Wed, 03 Dec 2008 15:21:21 GMT)
Cygnus Custom Marketing Honored by Custom Publishing Council with Pearl Award...
Cygnus Business Media, a leading diversified business-to-business media company, announced today that its Cygnus Custom Marketing division garnered a first place Gold Award at the Custom Publishing Council's fifth annual Pearl Awards for Best Overall Web Design for its portal CygnusCustomMarketing.com.
Source: PR Newswire via Yahoo! Finance (Wed, 03 Dec 2008 19:56:00 GMT)
Online ads stick to ASA rules, survey of digital marketing reveals ...
A report by the UK advertising regulator has found that companies are sticking to digital marketing rules. By Mark Sweney
Source: Guardian Unlimited (Wed, 03 Dec 2008 04:50:37 GMT)
News to know: Mumbai attacks, Microhoo, Holiday shopping, HDTVs ...
Here are today?s notable headlines. You can get News To Know via email alert and RSS daily: Jennifer Leggio: Mumbai attack coverage demonstrates (good and bad) maturation point of social media Social media marketing opportunism during tragedy = fail Oliver Marks: Mumbai Attacks : Knowledge is Power Larry Dignan: Icahn averages down on Yahoo; Searches for break even Icahn: 'I like Jerry'; Yahoo ...
Source: ZDNet (Mon, 01 Dec 2008 10:19:58 GMT)
R) Application For Marketing Authorisation With EMEA ...
Ark Therapeutics Group plc (AKT: LSE) ("Ark" or "the Company") today announces that the Marketing Authorisation Application (MAA) for CereproŽ, Ark's novel gene-based therapy for operable malignant glioma (brain cancer), has been filed with the European medicines regulatory agency (EMEA).
Source: Ark Files CereproMedical News Today (Tue, 02 Dec 2008 14:21:00 GMT)
darunavir) Receives Expanded Marketing Authorisation In The European Union For...
Tibotec Pharmaceuticals announced today that the European Commission adopted the decision to broaden the indication for PREZISTAŽ (darunavir), a protease inhibitor, in combination with ritonavir and other antiretroviral medicinal products to the treatment of HIV-1 infection in all treatment-experienced adult patients. Darunavir was developed by Tibotec Pharmaceuticals, Cork, Ireland.
Source: PREZISTAR Medical News Today (Wed, 03 Dec 2008 19:05:31 GMT)
© 2007 citedlive.com - all rights reserved